In a dramatic shift at the Indian box office, the devotional drama film Hanuman Ansh has transformed into a massive sleeper hit, steadily expanding its theatrical footprint across the country. The movie, which centers on the inspiring life of Neem Karoli Baba, faced severe initial hurdles after its premiere when competing releases heavily crowded the market. During its opening run, the film’s total show count dropped drastically from hundreds of screenings down to a minimal 25 shows nationwide. However, exceptional organic word-of-mouth and overwhelming audience emotional connections sparked a remarkable turnaround, forcing major multiplex chains to continuously re-allocate showtimes to meet skyrocketing demand. PVR INOX management confirmed that the film is recording exceptional theater occupancy rates, crossing over 50 percent during its fourth week run and expanding to over 1,500 active screens across India. Building on this triumphant domestic run, the makers are now preparing for a major global release starting September 11, distributed internationally by Hombale Films.
Conversely, the highly anticipated mega-budget action film Toxic, starring South superstar Yash, is experiencing a sharp decline in total screen availability. Although the big-ticket project enjoyed a massive opening weekend that generated over 150 crore rupees worldwide, it encountered noticeable momentum loss in subsequent days. The dropping footfalls have resulted in theater chains reducing show allocations for Toxic by roughly 45 percent, transferring those slots to Hanuman Ansh to capitalize on ongoing audience demand. Premium show formats have also taken a hit, with several major IMAX properties in key territories like Mumbai and Delhi-NCR scaling back Toxic to a single daily show as other international blockbuster titles take over prime time slots. Trade experts note that this box office clash serves as a classic demonstration of supply-and-demand dynamics, where genuine audience appreciation can elevate a modest film over star-led cinematic spectacles.